Covid 19 in India: Corona is wreaking havoc in many countries of the world including China. A large number of people are dying due to Corona infection. At the same time, in India too, the government is very cautious after the case of Omicron’s sub-variant BF.7 came to the fore. Vaccination campaign in India is going on continuously. The preparations related to Corona are being reviewed by the Central Government. Governments of many states including PM Modi are showing a lot of alert about the new variant.
Due to the increasing number of corona patients, health facilities in China have completely collapsed. At the same time, in view of the danger of new variants, the Government of India has issued several guidelines including random sampling.
review on corona virus
PM Modi held a high-level review meeting on 22 December regarding the situation of corona infection in the country. The Union Health Ministry on Wednesday reviewed the Kovid-19 situation in India in view of the increase in corona cases in several other countries including China and Japan. China is the only major country where cases have increased rapidly. In such a situation, it is important to consider whether India is safe from those factors which have created havoc in China. Some analyzes suggest that India is better protected than China and there is little chance of a China-like situation.
News Reels
How much of a threat is Omicron’s BF.7 variant?
Omicron’s new sub-variant BF.7, which is currently creating havoc in China, is present in India for the last several months. The central government has also said that people need not be afraid of this. The 4 patients who were found infected with this variant in India have now recovered. Cases of infection with the new variant were reported in Gujarat and Odisha. VK Paul, head of the National Task Force on Covid-19 and member of the Niti Aayog, also says that there is no need to panic. Sufficient tests are being done. India first detected the BF.7 sub-variant in a sample taken in July.
India’s Vaccines and Booster Doses
Vaccination campaign is going on continuously in India. Booster doses are also being given. It has also been proved in some studies that India’s vaccines work better than China’s. However, there is still a need to work better regarding the booster dose. 96 percent of the Kovid-19 vaccines being given in India are either Covishield and Covaxin prepared by Oxford or AstraZeneca. The vaccines being given in China are Coronavac and Sinopharm. The efficacy of the Oxford or AstraZeneca vaccine has been tested against CoronaVac. A study of one million people in Brazil found that both vaccines provided similar protection among young people, but that CoronaVac was less effective in the elderly.
Infection, Vaccination and Immunity
in india like china omicron The infection is not spreading from all variants of BF.7. Even expert doctors believe that this variant will be very less effective in India. Vaccination has happened faster in India than in China. In India, the effect of corona infection and the death rate also decreased gradually. China has not yet developed any m-RNA or adeno viral vaccine. Despite being behind in boosters, India has no chance of a wave like China. China’s strict lockdown also meant that fewer people in the country developed natural immunity to recent infections, while in India immunity developed in both ways.
read this also: Covid-19: ‘Corona’s variant XBB does not have symptoms of cough and fever’, Health Ministry told the truth of this viral message